Skip to content

Naval Medical Center San Diego (NMCSD) - Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain

Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00768248
Enrollment
2
Registered
2008-10-08
Start date
2008-10-31
Completion date
2010-01-31
Last updated
2019-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Phantom Limb, Stump Pain

Keywords

pain, phantom limb, stump pain, catheter, nerve block, peripheral nerve block, NMCSD, Post-Amputation Phantom Limb or Stump Pain

Brief summary

The purpose of this research study is to determine if putting local anesthetic-or numbing medication-through one or two tiny tube(s) placed next to the nerves that go to an amputated limb will decrease phantom limb and/or stump pain.

Detailed description

Specific Aim 1: To determine if, compared with current standard-of-care treatment, the addition of an ambulatory continuous peripheral nerve block decreases post-amputation phantom limb and stump pain. Hypothesis 1: Following upper or lower extremity amputation, phantom limb and/or stump pain will be significantly decreased four weeks following a multiple-day ambulatory continuous peripheral nerve block as compared with patients receiving standard-of-care treatment (as measured on the 11-point numeric rating scale). Specific Aim 2: To investigate the possible relationship between the addition of a multiple-day ambulatory continuous peripheral nerve block to standard-of-care treatment of post-amputation phantom limb and/or stump pain and cortical reorganization. Hypothesis 2: Following upper or lower extremity amputation with subsequent phantom limb pain/sensation and/or stump pain, the addition of a multiple-day ambulatory continuous peripheral nerve block to standard-of-care treatment will result in cortical reorganization during and four-weeks following the perineural infusion (as measured by MRI).

Interventions

ropivacaine 0.4%; the basal rate will be set at 7 mL/h

DRUGnormal saline (placebo)

the basal rate will be set at 7 mL/h

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* previous upper or lower limb amputation including at least one metacarpal or metatarsal bone, respectively * age 18 years or older * phantom limb and/or stump pain described as at least a 2 on the NRS for the previous week \[and pain occurring on a weekly basis over the previous month\] * willing to have an ambulatory perineural infusion for 6 days * willing to avoid additional new analgesic interventions from 4 weeks prior to at least 4 weeks following catheter placement, and preferably to 6 months following catheter placement * the availability of a caretaker who will transport the subject home following the procedure and remain with the subject for the first night of the infusion

Exclusion criteria

* known hepatic or renal insufficiency * allergy to the study medications * possessing a contraindication to perineural catheter placement or perineural local anesthetic infusion

Design outcomes

Primary

MeasureTime frame
Primary Analysis Will Compare the Two Treatment Groups for the Phantom Limb/Stump Pain Change From Baseline to 4 Weeks Following the Initial Catheter PlacementWeek 4

Secondary

MeasureTime frame
Physical Functioning · Brief Pain Inventorypre-intervention, then days 1, 3, 8, 28, 84, and 365
Emotional Functioning · Beck Depression Inventorypre-intervention; and then day 28 and 365 post-intervention
Nervous System Reorganization [if Patient Elected to Participate in the MRI Procedures] · MRI Procedurepre-intervention; and then 8 and 28 days post-intervention
Pain · 11-point Numeric Rating Scale of Pain Intensity · Usage of Baseline and Rescue Analgesics in Previous 24 Hours · Patient Global Impression of Change ScaleDay 8, Day 28, Month 12

Countries

United States

Participant flow

Recruitment details

Recruitment failed at this center (NMCSD)--two subject were enrolled but they did not have data collected \[coordinator simply did not collect the data\] and so this pilot study was closed without producing results.

Participants by arm

ArmCount
Active
3-7 days of perineural local anesthetic infusion perineural ropivacaine: ropivacaine 0.4%; the basal rate will be set at 7 mL/h
1
Placebo
3-7 days of perineural normal saline infusion normal saline (placebo): the basal rate will be set at 7 mL/h
1
Total2

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyResearch coordinator didn't collect data11

Baseline characteristics

CharacteristicPlaceboActiveTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants1 Participants2 Participants
Age, Continuous23 years24 years23.5 years
Region of Enrollment
United States
1 Participants1 Participants2 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
1 Participants1 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 10 / 1
serious
Total, serious adverse events
0 / 10 / 1

Outcome results

Primary

Primary Analysis Will Compare the Two Treatment Groups for the Phantom Limb/Stump Pain Change From Baseline to 4 Weeks Following the Initial Catheter Placement

Time frame: Week 4

Population: Recruitment failed at this center (NMCSD)--two subject were enrolled but they did not have data collected \[coordinator simply did not collect the data\] and so this pilot study was closed without producing results.

Secondary

Emotional Functioning · Beck Depression Inventory

Time frame: pre-intervention; and then day 28 and 365 post-intervention

Population: Recruitment failed at this center (NMCSD)--two subject were enrolled but they did not have data collected \[coordinator simply did not collect the data\] and so this pilot study was closed without producing results.

Secondary

Nervous System Reorganization [if Patient Elected to Participate in the MRI Procedures] · MRI Procedure

Time frame: pre-intervention; and then 8 and 28 days post-intervention

Population: Recruitment failed at this center (NMCSD)--two subject were enrolled but they did not have data collected \[coordinator simply did not collect the data\] and so this pilot study was closed without producing results.

Secondary

Pain · 11-point Numeric Rating Scale of Pain Intensity · Usage of Baseline and Rescue Analgesics in Previous 24 Hours · Patient Global Impression of Change Scale

Time frame: Day 8, Day 28, Month 12

Population: Recruitment failed at this center (NMCSD)--two subject were enrolled but they did not have data collected \[coordinator simply did not collect the data\] and so this pilot study was closed without producing results.

Secondary

Physical Functioning · Brief Pain Inventory

Time frame: pre-intervention, then days 1, 3, 8, 28, 84, and 365

Population: Recruitment failed at this center (NMCSD)--two subject were enrolled but they did not have data collected \[coordinator simply did not collect the data\] and so this pilot study was closed without producing results.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026